Annu H (Haridasani) Navani MD QME
Pain Medicine
Medical Director, Comprehensive Pain Management Center
Join to View Full Profile
3425 S Bascom AveSte 200Campbell, CA 95008
Phone+1 408-356-5292
Fax+1 408-356-5307
Dr. Navani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Medical College of Wisconsin Affiliated HospitalsResidency, Anesthesiology, 1998 - 2002
Medical College and Hospital KolkataClass of 1996
Certifications & Licensure
CA State Medical License 2001 - 2027
WI State Medical License 1999 - 2003
OH State Medical License 2001 - 2002
American Board of Anesthesiology Anesthesiology- American Board of Anesthesiology Pain Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- Diagnostic Guidance for Chronic Complex Regional Pain Syndrome Type I and Type II from The American Society of Interventional Physicians (ASIPP).Christopher Gharibo, Miles Day, Steve M Aydin, Alan D Kaye, Salahadin Abdi
Pain Physician. 2025-07-01 - Safety and Efficacy of Platelet-Rich Plasma versus Genicular Nerve Radiofrequency Ablation in Knee Osteoarthritis: An Open-Label, Prospective, Randomized, Clinical Trial.Shahzad Anwar, Swarnima Vardhan, Abhinav Aggarwal, Sulayman Waquar, Madhurima Vardhan
Pain Physician. 2025-05-01 - Innovative Approaches in Knee Osteoarthritis Treatment: A Comprehensive Review of Bone Marrow-Derived Products.José Fábio Lana, Joseph Purita, Madhan Jeyaraman, Bianca Freitas de Souza, Bruno Lima Rodrigues
Biomedicines. 2024-12-11
Press Mentions
Leading Charge in Regenerative & Longevity Medicine: Dr. Annu Navani’s Impact on Emerging HealthcareAugust 10th, 2025- Scilex, a Sorrento Company, Announces Pivotal Phase 3 SP-102 (SEMDEXA™) Data Presentation at the American Society of Interventional Pain (ASIPP) 2022 Annual MeetingMay 6th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
